Search

Your search keyword '"Dopamine metabolism"' showing total 1,160 results

Search Constraints

Start Over You searched for: Descriptor "Dopamine metabolism" Remove constraint Descriptor: "Dopamine metabolism" Publisher nature publishing group Remove constraint Publisher: nature publishing group
1,160 results on '"Dopamine metabolism"'

Search Results

1. Exogenous dopamine ameliorates chilling injury of banana fruits during cold storage.

2. Mating proximity blinds threat perception.

3. Constraints on the subsecond modulation of striatal dynamics by physiological dopamine signaling.

4. Explaining dopamine through prediction errors and beyond.

5. Enhanced cognitive flexibility and phasic striatal dopamine dynamics in a mouse model of low striatal tonic dopamine.

6. A feature-specific prediction error model explains dopaminergic heterogeneity.

7. GDNF improves the cognitive ability of PD mice by promoting glycosylation and membrane distribution of DAT.

8. Structures of the dopamine transporter point to ways to target addiction and disease.

9. Molecular basis of human noradrenaline transporter reuptake and inhibition.

10. Dopamine biases decisions by limiting temporal integration.

11. Dopamine reuptake and inhibitory mechanisms in human dopamine transporter.

12. Structure of the human dopamine transporter and mechanisms of inhibition.

13. Structure of the human dopamine transporter in complex with cocaine.

14. The PM20D1-NADA pathway protects against Parkinson's disease.

15. Single-dose methamphetamine administration impairs ORM retrieval in mice via excessive DA-mediated inhibition of PrL Glu activity.

16. Effects of psychedelic, DOI, on nucleus accumbens dopamine signaling to predictable rewards and cues in rats.

17. Efficient and rapid digestion of proteins with a dual-enzyme microreactor featuring 3-D pores formed by dopamine/polyethyleneimine/acrylamide-coated KIT-6 molecular sieve.

18. A neurotherapeutic approach with Lacticaseibacillus rhamnosus E9 on gut microbiota and intestinal barrier in MPTP-induced mouse model of Parkinson's disease.

19. Cognitive representations of intracranial self-stimulation of midbrain dopamine neurons depend on stimulation frequency.

20. Uncertainty of treatment efficacy moderates placebo effects on reinforcement learning.

21. The potential of a novel enzyme-based surface plasmon resonance biosensor for direct detection of dopamine.

22. Myelin plasticity in the ventral tegmental area is required for opioid reward.

23. Distinct µ-opioid ensembles trigger positive and negative fentanyl reinforcement.

24. Chronic ultraviolet irradiation induces memory deficits via dysregulation of the dopamine pathway.

25. Effects of cannabidiol in post-stroke mood disorders in neonatal rats.

26. Association between voriconazole-induced visual hallucination and dopamine in an analysis of the food and drug administration (FDA) adverse event reporting system database.

27. Intake of oligoelements with cytarabine or etoposide alters dopamine levels and oxidative damage in rat brain.

28. Structural insights into vesicular monoamine storage and drug interactions.

29. Brain connectivity changes to fast versus slow dopamine increases.

30. A brainstem-hypothalamus neuronal circuit reduces feeding upon heat exposure.

31. The cerebellum directly modulates the substantia nigra dopaminergic activity.

32. Cell senescence induced by toxic interaction between α-synuclein and iron precedes nigral dopaminergic neuron loss in a mouse model of Parkinson's disease.

33. State and rate-of-change encoding in parallel mesoaccumbal dopamine pathways.

34. Dynamic behaviour restructuring mediates dopamine-dependent credit assignment.

35. Dopaminergic neuron loss in mice due to increased levels of wild-type human α-Synuclein only takes place under conditions of accelerated aging.

36. Striatal dopamine neurotransmission is altered in age- and region-specific manner in a Parkinson's disease transgenic mouse.

37. CRISPR/sgRNA-directed synergistic activation mediator (SAM) as a therapeutic tool for Parkinson´s disease.

38. Ventral tegmental area glutamate neurons establish a mu-opioid receptor gated circuit to mesolimbic dopamine neurons and regulate opioid-seeking behavior.

39. Behavioral, neural and ultrastructural alterations in a graded-dose 6-OHDA mouse model of early-stage Parkinson's disease.

40. PLCγ1 in dopamine neurons critically regulates striatal dopamine release via VMAT2 and synapsin III.

41. Dopaminergic systems create reward seeking despite adverse consequences.

42. Dopaminergic error signals retune to social feedback during courtship.

43. Impaired cognitive and motor function are coincident with L-DOPA-induced dyskinesia in a model of Parkinson's disease.

44. Dopamine and glutamate regulate striatal acetylcholine in decision-making.

45. Intrinsic dopamine and acetylcholine dynamics in the striatum of mice.

46. Dopamine D2 receptors in nucleus accumbens cholinergic interneurons increase impulsive choice.

47. Quinpirole ameliorates nigral dopaminergic neuron damage in Parkinson's disease mouse model through activating GHS-R1a/D 2 R heterodimers.

48. Structural genomics of the human dopamine receptor system.

49. Increased glutamate and glutamine levels and their relationship to astrocytes and dopaminergic transmissions in the brains of adults with autism.

50. Circuit coordination of opposing neuropeptide and neurotransmitter signals.

Catalog

Books, media, physical & digital resources